Mechanisms of drug resistance in colon cancer and its therapeutic strategies

• Published in: World journal of gastroenterology : WJG Vol. 22; no. 30; pp. 6876 - 6889
• Main Authors: Hu, Tao, Li, Zhen, Gao, Chun-Ying, Cho, Chi Hin
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Inc 14-08-2016
• Subjects: Apoptosis; apoptosis;Autophagy; ATP Binding Cassette Transporter, Sub-Family B - antagonists & inhibitors; ATP Binding Cassette Transporter, Sub-Family B - physiology; ATP-Binding Cassette Transporters - analysis; ATP-Binding Cassette Transporters - physiology; Autophagy; cancer;Drug; cassette; Colon; Colonic Neoplasms - drug therapy; Colonic Neoplasms - metabolism; Colonic Neoplasms - pathology; Drug Resistance, Neoplasm; Humans; resistance;ATP-binding; Review; transporters;Evasion; Tumor Suppressor Protein p53 - physiology; ATP-binding cassette transporters; Colon cancer; Evasion of apoptosis; Drug resistance; Autophagy
• ISSN: 1007-9327; 2219-2840
• DOI: 10.3748/wjg.v22.i30.6876

Drug resistance develops in nearly all patients with colon cancer, leading to a decrease in the therapeutic efficacies of anticancer agents. This review provides an up-to-date summary on over-expression of ATPbinding cassette(ABC) transporters and evasion of apoptosis, two representatives of transport-based and non-transport-based mechanisms of drug resistance, as well as their therapeutic strategies. Different ABC transporters were found to be up-regulated in colon cancer, which can facilitate the efflux of anticancer drugs out of cancer cells and decrease their therapeutic effects. Inhibition of ABC transporters by suppressing their protein expressions or co-administration of modulators has been proven as an effective approach to sensitize drug-resistant cancer cells to anticancer drugs in vitro. On the other hand, evasion of apoptosis observed in drug-resistant cancers also results in drug resistance to anticancer agents, especially to apoptosis inducers. Restoration of apoptotic signals by BH3 mimetics or epidermal growth factor receptor inhibitors and inhibition of cancer cell growth by alternative cell death pathways, such as autophagy, are effective means to treat such resistant cancer types. Given that the drug resistance mechanisms are different among colon cancer patients and may change even in a single patient at different stages, personalized and specific combination therapy is proposed to be more effective and safer for the reversal of drug resistance in clinics.